The Bronchiolitis Obliterans Syndrome Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Bronchiolitis Obliterans Syndrome Market?
The market size for bronchiolitis obliterans syndrome has seen significant growth lately. The market, which was valued at $1.46 billion in 2024, is projected to increase to $1.59 billion in 2025. This represents a compound annual growth rate (CAGR) of 9.2%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Bronchiolitis Obliterans Syndrome Industry?
The bronchiolitis obliterans syndrome market is predicted to reach a value of $2.23 billion in 2029, growing at a compound annual growth rate (CAGR) of 8.9%.
Download Your Free Sample of the 2025 Bronchiolitis Obliterans Syndrome Market Report and Uncover Key Trends Now!
Global Market Segmentation: Identifying Major Bronchiolitis Obliterans Syndrome Industry Segments
The bronchiolitis obliterans syndrome market covered in this report is segmented –
1) By Treatment Type: Medication, Oxygen Therapy, Lung Transplant
2) By Diagnosis: Pulmonary Function Tests, Imaging Tests, Lung Biopsy, Other Diagnosis
3) By Disease Type: Acute Bronchiolitis, Chronic Bronchiolitis Obliterans Syndrome
4) By End-User: Hospitals, Specialty Clinics, Diagnostic Centers, Other End-Users
What are the Key Growth Drivers Fueling the Bronchiolitis Obliterans Syndrome Market?
The key drivers in the bronchiolitis obliterans syndrome marketare:
• Increasing number of lung transplant procedures worldwide
• A rising inflow of targeted BOS therapies
• Growing government and private funding for lesser-known diseases
• Increased demand for personalized medicine and biomarkers
Pre-order the 2025 Bronchiolitis Obliterans Syndrome Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Bronchiolitis Obliterans Syndrome Market?
The key trends in the bronchiolitis obliterans syndrome market are:
• Advancements in inhaled drug delivery systems are a key emerging trend.
• The integration of artificial intelligence in pulmonary diagnostics is shaping the future of the market.
• The development of precision medicine driven by technology is a significant trend.
• There are also developments happening in bioinformatics and clinical trial analytics and advancements in immunomodulatory therapies.
Who Are the Top Competitors & Leading Players in the Bronchiolitis Obliterans Syndrome Market?
Major companies in the bronchiolitis obliterans syndrome market are:
• Pfizer Inc.
• Boehringer Ingelheim
• University of California Health
• Texas Children’s Hospital
• Incyte Corporation
• Apollo Hospitals
• Mallinckrodt Pharmaceuticals plc
• Zambon Company S.p.A.
• Fortis Healthcare
• St. Louis Children's Hospital
• Mayo Foundation for Medical Education and Research
• Medicover Hospitals
• Renovion Inc.
• Mereo BioPharma Group PLC
• OrphAI Therapeutics
• Koutif Therapeutics
• ArkBio
• Altavant Sciences
• Breath Therapeutics
• University of Alberta Hospital
Regional Dominance: Which Area Leads the Global Bronchiolitis Obliterans Syndrome Market?
North America was the largest region in the bronchiolitis obliterans syndrome market in 2024
